Studies on the binding of botulinum toxin type A to the rat phrenic nerve-hemidiaphragm preparation.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001904:Botulinum Antitoxin / Q000494:pharmacology; D001905:Botulinum Toxins / Q000378:metabolism*; D003964:Diaphragm / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000378:metabolism; D009994:Osmolar Concentration; D010243:Paralysis / Q000139:chemically induced; D010791:Phrenic Nerve / Q000187:drug effects / Q000378:metabolism*; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D012965:Sodium Chloride / Q000494:pharmacology; D013395:Sucrose / Q000494:pharmacology; D013696:Temperature; D013997:Time Factors
D001904:Botulinum Antitoxin; D012965:Sodium Chloride; D013395:Sucrose; D010830:Physostigmine; D001905:Botulinum Toxins; D008274:Magnesium; D000109:Acetylcholine